Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2804028 | 1.00 | PRMT1 (1.00) | PRMT1ADRA1AEPHX2LMNATSHR | |
| SCHEMBL2804471 | 1.00 | PRMT1 (1.00) | PRMT1ADRA1AEPHX2LMNATSHR | |
| SCHEMBL17379963 | 1.00 | PRMT1 (1.00) | PRMT1ADRA1AEPHX2LMNATSHR | |
| SCHEMBL31475477 | 0.97 | PRMT1 (0.95) | PRMT1ADRA1AEPHX2LMNATSHR | |
| SCHEMBL31475480 | 0.90 | PRMT1 (0.81) | PRMT1ADRA1AEPHX2LMNATSHR | |
| SCHEMBL29050817 | 0.89 | EPHX2 (0.81) | PRMT1EPHX2TSHREPHX1PLA2G2A | |
| SCHEMBL18724674 | 0.89 | EPHX2 (0.81) | PRMT1ADRA1AEPHX2EPHX1PLA2G2A | |
| SCHEMBL22508816 | 0.89 | PRMT1 (0.80) | PRMT1ADRA1AEPHX2LMNATSHR | |
| SCHEMBL18724795 | 0.89 | EPHX2 (0.81) | PRMT1ADRA1AEPHX2EPHX1PLA2G2A | |
| SCHEMBL15743121 | 0.89 | EPHX2 (0.81) | PRMT1ADRA1AEPHX2EPHX1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025071268-A1 | POLYESTER RESIN HAVING EXCELLENT MECHANICAL PROPERTIES AND BIODEGRADABILITY, AND PREPARATION METHOD THEREFOR | 주식회사 삼양사 | 2025-04-03 | — | — | WO | disclosed |
| EP-3157978-B1 | STRICTLY SEGMENTED THERMOPLASTIC ELASTOMERS AS BIODEGRADABLE BIOMATERIALS | SYMO CHEM B V (NL) | 2021-08-11 | — | — | EP | disclosed |
| US-10556994-B2 | Strictly segmented thermoplastic elastomers as biodegradable biomaterials | SYMO-CHEM B.V. (NL) | 2020-02-11 | — | — | US | disclosed |
| US-20180334543-A1 | STRICTLY SEGMENTED THERMOPLASTIC ELASTOMERS AS BIODEGRADABLE BIOMATERIALS | SYMO-CHEM B.V. (NL) | 2018-11-22 | — | — | US | disclosed |
| EP-3157978-A1 | STRICTLY SEGMENTED THERMOPLASTIC ELASTOMERS AS BIODEGRADABLE BIOMATERIALS | Symo-chem B.V. (NL) | 2017-04-26 | — | — | EP | disclosed |
| WO-2015194961-A1 | STRICTLY SEGMENTED THERMOPLASTIC ELASTOMERS AS BIODEGRADABLE BIOMATERIALS | SYMO-CHEM B.V. (NL) | 2015-12-23 | — | — | WO | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196859-A1 | Novel antibacterial agents | ENGASE, PEPD, PGLS | PRMT1 2261/4885ADRA1A 4701/4885EPHX2 1118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.